Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Edwards Lifesciences Corporation

NYSE

Market Cap.

53.02B

Avg. Volume

3.28M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Edwards Lifesciences Corporation!

Still processing it, give me a bit more time...

Edwards Lifesciences Corporation News

Edwards Lifesciences Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Devices
edwards.com

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Edwards Lifesciences Corporation Earnings & Revenue

Edwards Lifesciences Corporation Financials

Table Compare

Compare EW metrics with:

   

Earnings & Growth

EW

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

EW

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

EW

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

EW

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Edwards Lifesciences Corporation Income

Edwards Lifesciences Corporation Balance Sheet

Edwards Lifesciences Corporation Cash Flow

Edwards Lifesciences Corporation Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Edwards Lifesciences Corporation Executives

NameRole
Mr. Bernard J. ZovighianChief Executive Officer & Director
Mr. Larry L. WoodCorporate Vice President and Group President of TAVR & Surgical Structural Heart
Mr. Scott B. UllemCorporate Vice President & Chief Financial Officer
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory Compliance
NameRoleGenderDate of BirthPay
Mr. Bernard J. ZovighianChief Executive Officer & DirectorMale19682.27M
Mr. Larry L. WoodCorporate Vice President and Group President of TAVR & Surgical Structural HeartMale19661.49M
Mr. Scott B. UllemCorporate Vice President & Chief Financial OfficerMale19671.35M
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate DevelopmentMale19621.27M
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory ComplianceMale1965

--

Edwards Lifesciences Corporation Insider Trades

Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares5625
Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionDisposed
TypeS-Sale
Shares5625
Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionDisposed
TypeM-Exempt
Shares5625
Date11 May
NameSELLERS ROBERT W.A.
RoleSVP, Corporate Controller
TransactionDisposed
TypeF-InKind
Shares229
Date11 May
NameSzyman Catherine M.
RoleCVP, Critical Care
TransactionDisposed
TypeF-InKind
Shares827
DateNameRoleTransactionTypeShares
21 MayUllem Scott B.CVP, Chief Financial OfficerAcquiredM-Exempt5625
21 MayUllem Scott B.CVP, Chief Financial OfficerDisposedS-Sale5625
21 MayUllem Scott B.CVP, Chief Financial OfficerDisposedM-Exempt5625
11 MaySELLERS ROBERT W.A.SVP, Corporate ControllerDisposedF-InKind229
11 MaySzyman Catherine M.CVP, Critical CareDisposedF-InKind827

Discover More

Streamlined Academy

Edwards Lifesciences Corporation

NYSE

Market Cap.

53.02B

Avg. Volume

3.28M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Edwards Lifesciences Corporation News

Edwards Lifesciences Corporation Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Edwards Lifesciences Corporation Earnings & Revenue

Edwards Lifesciences Corporation Income

Edwards Lifesciences Corporation Balance Sheet

Edwards Lifesciences Corporation Cash Flow

Edwards Lifesciences Corporation Financials Over Time

Edwards Lifesciences Corporation Executives

NameRole
Mr. Bernard J. ZovighianChief Executive Officer & Director
Mr. Larry L. WoodCorporate Vice President and Group President of TAVR & Surgical Structural Heart
Mr. Scott B. UllemCorporate Vice President & Chief Financial Officer
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate Development
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory Compliance
NameRoleGenderDate of BirthPay
Mr. Bernard J. ZovighianChief Executive Officer & DirectorMale19682.27M
Mr. Larry L. WoodCorporate Vice President and Group President of TAVR & Surgical Structural HeartMale19661.49M
Mr. Scott B. UllemCorporate Vice President & Chief Financial OfficerMale19671.35M
Mr. Donald E. Bobo Jr.Corporate Vice President of Strategy & Corporate DevelopmentMale19621.27M
Mr. Gary I. SorsherSenior Vice President of Quality & Regulatory ComplianceMale1965

--

Edwards Lifesciences Corporation Insider Trades

Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionAcquired
TypeM-Exempt
Shares5625
Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionDisposed
TypeS-Sale
Shares5625
Date21 May
NameUllem Scott B.
RoleCVP, Chief Financial Officer
TransactionDisposed
TypeM-Exempt
Shares5625
Date11 May
NameSELLERS ROBERT W.A.
RoleSVP, Corporate Controller
TransactionDisposed
TypeF-InKind
Shares229
Date11 May
NameSzyman Catherine M.
RoleCVP, Critical Care
TransactionDisposed
TypeF-InKind
Shares827
DateNameRoleTransactionTypeShares
21 MayUllem Scott B.CVP, Chief Financial OfficerAcquiredM-Exempt5625
21 MayUllem Scott B.CVP, Chief Financial OfficerDisposedS-Sale5625
21 MayUllem Scott B.CVP, Chief Financial OfficerDisposedM-Exempt5625
11 MaySELLERS ROBERT W.A.SVP, Corporate ControllerDisposedF-InKind229
11 MaySzyman Catherine M.CVP, Critical CareDisposedF-InKind827

Streamlined Academy

Website screenshot
HealthcareMedical - Devices
edwards.com

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides the PASCAL and Cardioband transcatheter valve repair systems for minimally-invasive therapy. In addition, it offers surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; KONECT RESILIA, a pre-assembled aortic tissue valved conduit for patients who require replacement of the valve, root, and ascending aorta; and HARPOON Beating Heart Mitral Valve Repair System for patients with degenerative mitral regurgitation. Further, the company provides critical care solutions, including advanced hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Edwards Lifesciences Corporation!

Still processing it, give me a bit more time...

Edwards Lifesciences Corporation Financials

Table Compare

Compare EW metrics with:

   

Earnings & Growth

EW

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

EW

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

EW

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

EW

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Edwards Lifesciences Corporation Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsBuy
Return on EquityStrong Buy
Return on AssetsStrong Buy
Debt/Equity RatioNeutral
Price/Earnings RatioStrong Buy
Price/Book RatioStrong Buy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More